Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 6Gastrointestinal 4CNS 3Thoracic 2Other hematologic neoplasm 2Sarcoma 1Myeloid 1Lymphoid 1Head & Neck 1Dermatologic 1Classical hematology 1Breast 1

Conditions

Glioblastoma 527Brain Neoplasms 415Glioma 343Astrocytoma 239Central Nervous System Neoplasms 201Neuroblastoma 195Gliosarcoma 163Oligodendroglioma 149Medulloblastoma 118Neoplasms 113Ependymoma 72Recurrence 70Breast Neoplasms 69Sarcoma 65Melanoma 62Carcinoma, Non-Small-Cell Lung 58Osteosarcoma 57Diffuse Intrinsic Pontine Glioma 48Wilms Tumor 47Familial ependymoma 47Lymphoma 46Neoplasm Metastasis 45Optic Nerve Glioma 44Rhabdomyosarcoma 42Rhabdoid Tumor 42Lung Neoplasms 42Choroid Plexus Neoplasms 42Neuroectodermal Tumors, Primitive 38Meningeal Carcinomatosis 38Ovarian Neoplasms 37

Interventions

Interferon-beta 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Adenoviridae Infections × CNS × Clear all
NCT06585527 2024-10-31

Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma

Beijing Neurosurgical Institute

Phase 1 Recruiting
30 enrolled
CNS

Adenoviridae Infections, Glioblastoma, Glioma

NCT03072134 2023-01-20

Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma

Northwestern University

Phase 1 Completed
12 enrolled 13 charts
CNS

Adenoviridae Infections, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

NCT00031083 2020-11-17

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Biogen

Phase 1 Completed
12 enrolled
CNSSarcoma

Adenoviridae Infections, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡